SeaSpine Holdings Corporation (SPNE) Downgraded by Zacks Investment Research to “Hold”

SeaSpine Holdings Corporation (NASDAQ:SPNE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

According to Zacks, “SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California. “

Other equities research analysts have also issued research reports about the company. BTIG Research assumed coverage on SeaSpine Holdings Corporation in a research report on Tuesday, June 20th. They set a “buy” rating on the stock. HC Wainwright began coverage on SeaSpine Holdings Corporation in a report on Monday, July 10th. They set a “buy” rating and a $15.00 target price on the stock. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $22.00 target price on shares of SeaSpine Holdings Corporation in a report on Sunday, August 20th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $16.67.

Shares of SeaSpine Holdings Corporation (SPNE) traded up 2.33% during trading on Tuesday, hitting $11.40. The stock had a trading volume of 2,892 shares. The stock’s market capitalization is $143.08 million. The stock has a 50 day moving average price of $10.71 and a 200-day moving average price of $10.71. SeaSpine Holdings Corporation has a one year low of $6.40 and a one year high of $11.52.

TRADEMARK VIOLATION NOTICE: “SeaSpine Holdings Corporation (SPNE) Downgraded by Zacks Investment Research to “Hold”” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2017/10/10/seaspine-holdings-corporation-spne-downgraded-by-zacks-investment-research-to-hold.html.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Schwab Charles Investment Management Inc. lifted its holdings in SeaSpine Holdings Corporation by 1.0% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 18,707 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 190 shares during the period. Northern Trust Corp lifted its holdings in SeaSpine Holdings Corporation by 2.3% during the 2nd quarter. Northern Trust Corp now owns 24,869 shares of the medical equipment provider’s stock worth $286,000 after buying an additional 559 shares during the period. UBS Asset Management Americas Inc. lifted its holdings in SeaSpine Holdings Corporation by 1.7% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 134,891 shares of the medical equipment provider’s stock worth $1,554,000 after buying an additional 2,209 shares during the period. FNY Partners Fund LP lifted its holdings in SeaSpine Holdings Corporation by 7.6% during the 2nd quarter. FNY Partners Fund LP now owns 41,000 shares of the medical equipment provider’s stock worth $472,000 after buying an additional 2,902 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in SeaSpine Holdings Corporation by 2.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 249,499 shares of the medical equipment provider’s stock worth $2,874,000 after buying an additional 5,655 shares during the period. 39.03% of the stock is currently owned by hedge funds and other institutional investors.

SeaSpine Holdings Corporation Company Profile

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering f

According to Zacks, “SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California. “

Other equities research analysts have also issued research reports about the company. BTIG Research assumed coverage on SeaSpine Holdings Corporation in a research report on Tuesday, June 20th. They set a “buy” rating on the stock. HC Wainwright began coverage on SeaSpine Holdings Corporation in a report on Monday, July 10th. They set a “buy” rating and a $15.00 target price on the stock. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $22.00 target price on shares of SeaSpine Holdings Corporation in a report on Sunday, August 20th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $16.67.

Shares of SeaSpine Holdings Corporation (SPNE) traded up 2.33% during trading on Tuesday, hitting $11.40. The stock had a trading volume of 2,892 shares. The stock’s market capitalization is $143.08 million. The stock has a 50 day moving average price of $10.71 and a 200-day moving average price of $10.71. SeaSpine Holdings Corporation has a one year low of $6.40 and a one year high of $11.52.

TRADEMARK VIOLATION NOTICE: “SeaSpine Holdings Corporation (SPNE) Downgraded by Zacks Investment Research to “Hold”” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2017/10/10/seaspine-holdings-corporation-spne-downgraded-by-zacks-investment-research-to-hold.html.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Schwab Charles Investment Management Inc. lifted its holdings in SeaSpine Holdings Corporation by 1.0% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 18,707 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 190 shares during the period. Northern Trust Corp lifted its holdings in SeaSpine Holdings Corporation by 2.3% during the 2nd quarter. Northern Trust Corp now owns 24,869 shares of the medical equipment provider’s stock worth $286,000 after buying an additional 559 shares during the period. UBS Asset Management Americas Inc. lifted its holdings in SeaSpine Holdings Corporation by 1.7% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 134,891 shares of the medical equipment provider’s stock worth $1,554,000 after buying an additional 2,209 shares during the period. FNY Partners Fund LP lifted its holdings in SeaSpine Holdings Corporation by 7.6% during the 2nd quarter. FNY Partners Fund LP now owns 41,000 shares of the medical equipment provider’s stock worth $472,000 after buying an additional 2,902 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in SeaSpine Holdings Corporation by 2.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 249,499 shares of the medical equipment provider’s stock worth $2,874,000 after buying an additional 5,655 shares during the period. 39.03% of the stock is currently owned by hedge funds and other institutional investors.

SeaSpine Holdings Corporation Company Profile

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Receive News & Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply